These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8944811)

  • 1. The role of matrix metalloproteinases in heart disease.
    Cleutjens JP
    Cardiovasc Res; 1996 Nov; 32(5):816-21. PubMed ID: 8944811
    [No Abstract]   [Full Text] [Related]  

  • 2. Matrix metalloproteinases in epithelia from human recurrent corneal erosion.
    Garrana RM; Zieske JD; Assouline M; Gipson IK
    Invest Ophthalmol Vis Sci; 1999 May; 40(6):1266-70. PubMed ID: 10235563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical study of matrix metalloproteinases and their tissue inhibitors in pulmonary Langerhans' cell granulomatosis.
    Hayashi T; Rush WL; Travis WD; Liotta LA; Stetler-Stevenson WG; Ferrans VJ
    Arch Pathol Lab Med; 1997 Sep; 121(9):930-7. PubMed ID: 9302924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Matrix metalloproteinases and cancer. Role and control].
    Hornebeck W
    Bull Cancer; 1992; 79(3):221-5. PubMed ID: 1392160
    [No Abstract]   [Full Text] [Related]  

  • 5. [Localization of matrix metalloproteinases in tracheobronchomalacia: preliminary report].
    Sai M; Niwa H; Yamakawa Y; Ninoyu K; Yokochi T; Masaoka A
    Nihon Geka Gakkai Zasshi; 1994 Mar; 95(3):206. PubMed ID: 8177205
    [No Abstract]   [Full Text] [Related]  

  • 6. Activation mechanisms of matrix metalloproteinases.
    Nagase H
    Biol Chem; 1997; 378(3-4):151-60. PubMed ID: 9165065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2.
    Deryugina EI; Bourdon MA; Reisfeld RA; Strongin A
    Cancer Res; 1998 Aug; 58(16):3743-50. PubMed ID: 9721888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial proteases and matrix remodeling in inflammatory heart disease.
    Rutschow S; Li J; Schultheiss HP; Pauschinger M
    Cardiovasc Res; 2006 Feb; 69(3):646-56. PubMed ID: 16417902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.
    Spinale FG
    Physiol Rev; 2007 Oct; 87(4):1285-342. PubMed ID: 17928585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metalloproteinases in vascular wall remodelling].
    Domenech R
    Rev Med Chil; 1997 Jan; 125(1):63-5. PubMed ID: 9336071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases as targets for therapy in equine joint diseases.
    Hollander AP
    Equine Vet J; 1997 Sep; 29(5):329-30. PubMed ID: 9306055
    [No Abstract]   [Full Text] [Related]  

  • 12. Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix.
    Stetler-Stevenson WG
    Am J Pathol; 1996 May; 148(5):1345-50. PubMed ID: 8623905
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of matrix metalloproteinases activity on outflow in perfused human organ culture.
    Bradley JM; Vranka J; Colvis CM; Conger DM; Alexander JP; Fisk AS; Samples JR; Acott TS
    Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2649-58. PubMed ID: 9856774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of matrix proteolysis in angiogenesis].
    Silvestre JS; Lévy BI
    Journ Annu Diabetol Hotel Dieu; 2002; ():23-32. PubMed ID: 12525128
    [No Abstract]   [Full Text] [Related]  

  • 15. Extracellular matrix remodelling: the role of matrix metalloproteinases.
    Stamenkovic I
    J Pathol; 2003 Jul; 200(4):448-64. PubMed ID: 12845612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MMP-9 from TNF alpha-stimulated keratinocytes binds to cell membranes and type I collagen: a cause for extended matrix degradation in inflammation?
    Mäkelä M; Salo T; Larjava H
    Biochem Biophys Res Commun; 1998 Dec; 253(2):325-35. PubMed ID: 9878537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal expression of extracellular matrix metalloproteinases and tissue plasminogen activator in the development of collateral vessels in the canine model of coronary occlusion.
    Tyagi SC; Kumar S; Cassatt S; Parker JL
    Can J Physiol Pharmacol; 1996 Aug; 74(8):983-95. PubMed ID: 8960389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A structural diaster: an indermining of underpinnings.
    Weber KT
    Cardiovasc Res; 1996 Nov; 32(5):814-5. PubMed ID: 9138863
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulation of collagen prolyl 4-hydroxylase and matrix metalloproteinases in fibrosarcoma cells by hypoxia.
    Fähling M; Perlewitz A; Doller A; Thiele BJ
    Comp Biochem Physiol C Toxicol Pharmacol; 2004 Oct; 139(1-3):119-26. PubMed ID: 15556073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of latanoprost on the extracellular matrix of the ciliary muscle. A study on cultured cells and tissue sections.
    Ocklind A
    Exp Eye Res; 1998 Aug; 67(2):179-91. PubMed ID: 9733584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.